ClinicalTrials.Veeva

Menu

Sepsis Pre-Alert Monitoring Intervention: Study to Investigate Targeted Enhanced Monitoring for Sepsis

NYU Langone Health logo

NYU Langone Health

Status

Withdrawn

Conditions

Sepsis

Treatments

Other: Confusion Assessment method for the ICU (CAM-ICU)
Other: Vital Signs at 2 Hours

Study type

Interventional

Funder types

Other

Identifiers

NCT03473769
17-01565

Details and patient eligibility

About

Sepsis is a leading cause of death worldwide, and contributes to approximately 750,000 hospitalizations per year, a third of which may die. International guidelines recommend timely interventions, including cultures, fluid resuscitation and antibiotics. Following guideline bundles is associated with a decrease in mortality. Key to timely intervention is timely diagnosis.

Using the Epic sepsis predictive analytic tool, investigators will trigger vital sign and delirium monitoring in patients determined to be at increased risk for developing future sepsis.

The primary objective of this study is to demonstrate reduced mortality in patients for whom the pre-sepsis algorithm threshold is met, and who enhanced monitoring.

Full description

A means to identify patients before they become ill may improve the effectiveness of established therapies.Epic's electronic medical record (Epic systems, Verona, WI) contains a surveillance tool that uses predictive analytics to identify patients at risk of becoming septic four hours after the alert becomes active. This affords the opportunity to intervene sooner, but it remains unclear what the best course of action should be in a population at risk of sepsis, only some of which may go on to develop the illness. We propose an automatic intervention, consisting of enhanced monitoring, that is tied to the alert. No therapeutics will be mandated. Instead, additional monitoring information will lead to faster diagnosis and therapy, and improved clinical outcomes.

Sex

All

Ages

18 to 110 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • any inpatient at NYU Langone Health System

Exclusion criteria

  • not an inpatient at NYU Langone Health System

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

Double Blind

0 participants in 2 patient groups

Vital Signs at 2 Hours + CAM-ICU
Experimental group
Description:
enhanced vital sign and delirium monitoring in patients for who the per-sepsis algorithm reaches alert threshold.
Treatment:
Other: Vital Signs at 2 Hours
Other: Confusion Assessment method for the ICU (CAM-ICU)
No Intervention
No Intervention group
Description:
No intervention. Patient treated per standard of care.

Trial contacts and locations

1

Loading...

Central trial contact

Germaine Cuff

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems